Biggest News Aggregation in the World
📰 Caption Management News

Page 4 - Caption Management News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Caption Management. Real-time updates on events, politics, business and more.

Zacks: Analysts Anticipate Radius Global Infrastructure, Inc. (NASDAQ:RADI) to Announce -$0.02 Earnings Per Share

Analysts expect that Radius Global Infrastructure, Inc. (NASDAQ:RADI – Get Rating) will report ($0.02) earnings per share for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Radius Global Infrastructure’s earnings. The company is scheduled to issue its next earnings results on Monday, January 1st. According to Zacks, analysts expect that […]
United States Thomson Reuter Raymond James Gabelli Funds Berenberg Bank Caption Management

nCino (NASDAQ:NCNO) Receives New Coverage from Analysts at Morgan Stanley

Equities research analysts at Morgan Stanley assumed coverage on shares of nCino (NASDAQ:NCNO – Get Rating) in a research note issued to investors on Wednesday, The Fly reports. The brokerage set an “overweight” rating on the stock. Several other equities research analysts also recently issued reports on NCNO. KeyCorp cut their price objective on shares […]
New York United States Joshual Glover Piper Sandler Pierre Naude Robertw Baird

Recent Investment Analysts' Ratings Changes for nCino (NCNO)

A number of research firms have changed their ratings and price targets for nCino (NASDAQ: NCNO): 4/4/2022 – nCino had its price target lowered by analysts at Robert W. Baird from $60.00 to $55.00. 4/1/2022 – nCino had its price target lowered by analysts at Piper Sandler from $80.00 to $55.00. They now have an […]
New York United States Thomson Reuter Piper Sandler Pierre Naude Robertw Baird

Celularity (NASDAQ:CELU) Cut to "Hold" at Zacks Investment Research

Zacks Investment Research lowered shares of Celularity (NASDAQ:CELU – Get Rating) from a buy rating to a hold rating in a report published on Monday, Zacks.com reports. According to Zacks, “Celularity Inc. is a clinical stage biotechnology company. It involved in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified […]
Penserra Capital Management Caption Management Zacks Investment Research Lazard Asset Management Marshall Wace Gx Acquisition Corp

Brokerages Expect Lennar Co. (NYSE:LEN) Will Announce Earnings of $3.99 Per Share

Analysts predict that Lennar Co. (NYSE:LEN – Get Rating) will report earnings of $3.99 per share for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Lennar’s earnings, with estimates ranging from $3.86 to $4.17. Lennar posted earnings per share of $2.95 during the same quarter last year, which indicates a positive […]
United States Thomson Reuter Pacer Advisors Inc Caption Management Zacks Investment Research Financial Services

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Lennar (NYSE:LEN) Downgraded by StockNews.com

StockNews.com cut shares of Lennar (NYSE:LEN – Get Rating) from a buy rating to a hold rating in a research report released on Saturday. A number of other research analysts have also weighed in on LEN. BTIG Research cut their price target on shares of Lennar from $135.00 to $118.00 and set a buy rating […]
United States Caption Management Financial Services Empirical Finance Wells Fargo Company Phoenix Holdings Ltd

Lennar (NYSE:LEN) Price Target Lowered to $95.00 at Wells Fargo & Company

Lennar (NYSE:LEN – Get Rating) had its target price reduced by Wells Fargo & Company from $115.00 to $95.00 in a research report released on Friday morning, The Fly reports. They currently have an equal weight rating on the construction company’s stock. A number of other brokerages also recently weighed in on LEN. KeyCorp cut […]
United States Raymond James Pacer Advisors Inc Lennar Company Profile Get Rating Caption Management Financial Services

Celularity (NASDAQ:CELU) Shares Down 13.7%

Celularity Inc (NASDAQ:CELU – Get Rating)’s stock price traded down 13.7% during trading on Monday . The company traded as low as $7.60 and last traded at $7.77. 8,943 shares traded hands during mid-day trading, a decline of 96% from the average session volume of 206,427 shares. The stock had previously closed at $9.00. A […]
Penserra Capital Management Morgan Stanley Geode Capital Management Caption Management Zacks Investment Research Blackrock Inc

Morgan Stanley Cuts Ambarella (NASDAQ:AMBA) Price Target to $164.00

Ambarella (NASDAQ:AMBA – Get Rating) had its target price reduced by Morgan Stanley from $229.00 to $164.00 in a research report released on Tuesday, PriceTargets.com reports. They currently have an overweight rating on the semiconductor company’s stock. Several other brokerages also recently issued reports on AMBA. Stifel Nicolaus boosted their price target on shares of […]
Stifel Nicolaus Chanw Lee Feng Ming Wang Arrowmark Colorado Holdings Morgan Stanley Securities Exchange Commission

Ambarella (NASDAQ:AMBA) Price Target Lowered to $130.00 at Bank of America

Ambarella (NASDAQ:AMBA – Get Rating) had its price target lowered by Bank of America from $140.00 to $130.00 in a report issued on Tuesday, PriceTargets.com reports. The firm currently has an underperform rating on the semiconductor company’s stock. Several other equities analysts also recently weighed in on AMBA. Stifel Nicolaus decreased their target price on […]
United States Stifel Nicolaus Chi Hong Ju Feng Ming Wang Robertw Baird Craig Hallum

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science